bims-camemi Biomed News
on Mitochondrial metabolism in cancer
Issue of 2026–11–22
forty-one papers selected by
Christian Frezza, Universität zu Köln



  1. Sci Adv. 2026 Nov 20. 12(47): eaeg4754
      Mitochondrial homeostasis is maintained by molecular chaperones and proteases located within the organelle. The mitochondrial matrix-localized protease LONP-1 degrades oxidatively damaged or misfolded proteins. Importantly, LONP-1 also regulates mitochondrial DNA replication. Here, we show that mutations in C. elegans that impair LONP-1 function cause dysregulation of mitochondrial DNA replication, mitochondrial RNA transcription and protein synthesis within the mitochondrial matrix. LONP-1 deficient worms had reduced levels of oxidative phosphorylation proteins despite increased mtDNA-encoded protein synthesis. Via a forward genetic screen, we identified three mutations that restored mitochondrial function and the rate of development in lonp-1 mutants to levels comparable to those in wildtype worms. Interestingly, all three suppressor mutations were found in genes encoding mitochondrial ribosome proteins. A point mutation in the mitochondrial ribosome protein MRPS-38 restored oxidative phosphorylation in lonp-1 mutant worms. Combined, our results suggest that LONP-1 regulates mitochondrial translation and that suppressor mutations within mrps-38 or mrps-15 can enhance oxidative phosphorylation complex assembly when LONP-1 function is diminished.
    DOI:  https://doi.org/10.1126/sciadv.aeg4754
  2. Sci Adv. 2026 Nov 20. 12(47): eaeg6837
      The perinatal heart undergoes a rapid metabolic transition from glycolysis to fatty acid oxidation that requires extensive mitochondrial remodeling, yet the molecular checkpoints that coordinate this process remain poorly defined. Using temporally resolved proteomics and complexome profiling of developing mouse hearts from late gestation through early postnatal life (E18.5 to P10), we identify a discrete developmental window in which respiratory chain architecture is remodeled to enable metabolic commitment. Complex IV (CIV) emerges as a central structural determinant of this transition, undergoing isoform-specific reassembly and transient suppression at birth before incorporation into mature respiratory supercomplexes. We identify the CIV subunit COX7C as a developmentally regulated determinant of CIV maturation, with its abundance increasing during maximal respirasome assembly and the switch to fatty acid oxidation. Loss of COX7C impairs terminal CIV maturation, prevents incorporation of heart-specific isoforms, and destabilizes the respirasome organization. Notably, this defect causes a selective secondary failure of complex I completion, demonstrating that respirasome formation is required for catalytic CI maturation in vivo. Consequently, cardiac-specific COX7C deficiency fails to complete the perinatal metabolic transition, leading to the collapse of fatty acid oxidation, activation of nucleotide and serine-glycine-one-carbon metabolism, attenuated activation of the mitochondrial integrated stress response, and a metabolically and structurally compromised state unlikely to support the increasing energetic demands of the postnatal heart. Together, these findings define a developmentally timed, CIV-dependent assembly step that couples respiratory chain assembly to postnatal cardiac metabolic fate and provide a temporal framework for mitochondrial maturation in the developing heart.
    DOI:  https://doi.org/10.1126/sciadv.aeg6837
  3. bioRxiv. 2026 Nov 14. pii: 2026.09.18.752798. [Epub ahead of print]
      Isocitrate dehydrogenase (IDH) is the most frequently mutated metabolic enzyme in human cancers. Mutant IDH produces D-2-hydroxyglutarate (D-2HG), which promotes tumorigenesis through epigenetic alterations. Beyond cell-autonomous effects, tumor-derived D-2HG acts as a potent immunosuppressant that establishes an immune-cold tumor microenvironment (TME). However, the mechanism by which D-2HG is released from tumors remains largely unknown. Here, we identify the SWELL1 (LRRC8A)/LRRC8C-containing volume-regulated anion channel (VRAC) as a principal pathway for D-2HG efflux from IDH-mutant cells. Deletion of SWELL1, the essential VRAC subunit, markedly reduces D-2HG release and reverses associated immunosuppression in an orthotopic mouse model of IDH-mutant glioma. Strikingly, VRAC loss causes intracellular D-2HG accumulation, which paradoxically limits glioma proliferation by driving epigenetic remodeling and mitochondrial metabolic stress. Pharmacological VRAC inhibition with dicumarol suppresses IDH-mutant glioma growth, enhances intratumoral T cell activation, synergizes with immune checkpoint blockade, and prolongs survival in tumor-bearing mice. In human IDH-mutant lower-grade gliomas, elevated LRRC8C expression correlates inversely with DNA hypermethylation and positively with an immunosuppressive TME, and is associated with poor survival. Together, these findings establish VRAC-mediated D-2HG export as a previously unrecognized D-2HG clearance pathway that promotes both immune evasion and tumor cell fitness, uncovering new therapeutic opportunities beyond direct inhibition of D-2HG synthesis.
    DOI:  https://doi.org/10.64898/2026.09.18.752798
  4. bioRxiv. 2026 Nov 13. pii: 2026.11.12.766318. [Epub ahead of print]
      NRF2 hyperactivation caused by mutations in KEAP1 or NFE2L2 occurs in 20-30% of non-small cell lung cancers and confers therapy resistance. Here we show that NRF2-driven metabolic reprogramming creates a selective vulnerability to selenite. NRF2-dependent thiol export promotes the extracellular reduction of selenite to selenide. Our data support a model in which selenide enters cells and reaches mitochondria, where sulfide-quinone oxidoreductase uses selenide and glutathione to generate the selenopersulfide GS-SeH. A four-hour pulse of selenite was sufficient to induce cell death after washout, consistent with a selenium redox cycle that consumes NADPH and regenerates selenide. Within hours, selenite abolished aconitase activity and impaired mitochondrial respiration. The resulting cell death occurred independently of apoptosis, ferroptosis, pyroptosis, necroptosis and disulfidptosis. In mice, a selenite-rich diet selectively suppressed the growth of NRF2-hyperactive tumors. These findings identify an NRF2-driven metabolic vulnerability and support further investigation of selenite as a therapeutic strategy for NRF2-hyperactive cancers.
    DOI:  https://doi.org/10.64898/2026.11.12.766318
  5. EMBO Mol Med. 2026 Nov 17.
      Mitochondria and lysosomes are central regulators of cellular metabolism, nutrient sensing, cellular quality control, and stress adaptation. Although traditionally studied as independent organelles, it is now evident that they operate as an integrated functional network through multiple modes of communication, including membrane contact sites, signaling pathways, and selective vesicular trafficking. Disruption of this crosstalk is increasingly recognized as a common feature of mitochondrial disorders, lysosomal storage diseases, neurodegeneration, cardiovascular disease, and aging, highlighting its importance for cellular and tissue homeostasis. While mitophagy has long been considered the principal interface between mitochondria and lysosomes, recent discoveries have revealed a much broader communication landscape in which bidirectional signaling, ion exchange, lipid transfer, and mitochondria-derived vesicles coordinate organelle function independently of bulk degradation. In this Review, we discuss the molecular mechanisms that mediate mitochondria-lysosome communication, emphasizing emerging concepts in inter-organelle signaling and membrane contact biology. We further examine how disruption of these pathways contributes to human disease and consider the growing evidence that restoring mitochondria-lysosome communication, rather than targeting either organelle in isolation, represents a promising therapeutic strategy.
    DOI:  https://doi.org/10.1038/s44321-026-00556-9
  6. Nature. 2026 Nov 18.
      Ferroptosis, a form of cell death induced by overwhelming membrane lipid peroxidation, is a vulnerability of many cancers, including cancers resistant to current molecular and immune-based therapies1-7. Triggering of ferroptosis therefore provides an opportunity to achieve elimination of difficult-to-treat cancers1-4,8,9. Studies in mouse cancer models have demonstrated that anticancer immunity, mediated by dendritic cells (DCs) and CD8+ T cells, is essential for effective tumour eradication by ferroptosis-inducing strategies10-13. However, ferroptotic cells limit this response8-10,14, resulting in immune escape and tumour growth through mechanisms that remain unclear. Here we demonstrate that ferroptotic cancer cells activate a molecular program resulting in aberrant production of prostaglandin E2 (PGE2), which limits the stimulation of anticancer CD8+ T cell responses by type 1 conventional DCs (cDC1s), thereby promoting immune escape. In ferroptotic cancer cells, lipid peroxidation-mediated membrane permeabilization enables Ca2+ influx, which activates p38 MAPK signalling and thereby drives PGE2 production. This signalling axis is uncoupled from cancer cell death and can be targeted to selectively interfere with immune-inhibitory PGE2 production while preserving ferroptotic cancer cell elimination. In the context of cancer cell ferroptosis, ablation of PGE2 production or disrupting PGE2 signalling restores cDC1-mediated anticancer CD8+ T cell responses and leads to effective tumour elimination. Our findings identify a key mechanism that limits antitumour immunity and prevents tumour elimination upon ferroptosis induction in cancer cells, which could be exploited for cancer therapy.
    DOI:  https://doi.org/10.1038/s41586-026-11333-6
  7. Trends Biochem Sci. 2026 Nov 16. pii: S0968-0004(26)00329-4. [Epub ahead of print]
      Over the past two decades, we have gained an appreciation for how intracellular purine demand is met. Under nutrient-depleted conditions that activate purine biosynthesis, the enzymes of de novo purine biosynthesis compartmentalize into dynamic metabolons, called purinosomes, allowing the clustered channeling of intermediates between catalytic sites and overcoming the constraints of diffusive metabolic networks to produce purine nucleotides more efficiently. The discovery of the purinosome has reignited interest in a paradigm first described over forty years ago regarding how metabolism is organized within cells. Here, we discuss recent efforts to understand the organization of de novo purine biosynthetic enzymes within the purinosome, the impact of subcellular localization on purine production, and growing evidence that this phenomenon is conserved across species.
    Keywords:  biomolecular condensate; de novo purine biosynthesis; metabolism; metabolon; purinosome
    DOI:  https://doi.org/10.1016/j.tibs.2026.10.005
  8. Cell Rep. 2026 Nov 14. pii: S2211-1247(26)01361-6. [Epub ahead of print]45(11): 118282
      Clear cell renal cell carcinoma (ccRCC) is characterized by aberrant lipid accumulation and intrinsic ferroptosis sensitivity, yet how ccRCC escapes this vulnerability remains poorly understood. Here, we report that fumarate hydratase (FH) deficiency drives fumarate accumulation, which induces extensive remodeling of the ubiquitinated proteome and confers increased resistance to ferroptosis in ccRCC. Mechanistically, fumarate-mediated C706 succination of ubiquitin-like modifier-activating enzyme 1 (UBA1) significantly impairs its interaction with ubiquitin-conjugating enzyme E2 G2 (UBE2G2), concomitant with a global reduction of ubiquitination. Specifically, diminished ubiquitination increases the protein levels of activating transcription factor 4 (ATF4) and elevates solute carrier family 7 member 11 (SLC7A11) expression, thereby inhibiting ferroptosis. Importantly, a designed cell-penetrating peptide attenuates fumarate-induced UBA1 succination, suppresses ATF4-SLC7A11 axis, and enhances ferroptosis sensitivity of ccRCC. Collectively, these findings reveal that FH deficiency drives ubiquitinome dysregulation and suppresses ferroptosis, thereby linking ubiquitinated proteome reprogramming to tumor progression and suggesting potential therapeutic targets and strategies for treating ccRCC.
    Keywords:  CP: cancer; CP: metabolism; ccRCC; ferroptosis; fumarate; succination; ubiquitinated proteome
    DOI:  https://doi.org/10.1016/j.celrep.2026.118282
  9. Cell Metab. 2026 Nov 18. pii: S1550-4131(26)00454-7. [Epub ahead of print]
      While high-fat diets (HFDs) cause hyperphagia and obesity, ketogenic diets (KDs) generally reduce food intake and body weight. In C57BL/6J (B6J) but not C57BL/6NJ (B6NJ) mice, a KD with 5% protein (KD-5%P) induced hypophagia, weight loss, and hypoglycemia, whereas the same diet with 10% protein (KD-10%P) increased adiposity and glucose intolerance. KD-5%P increased GDF15 and LCN2 in B6J mice, and GFRAL-neuron ablation blunted weight loss. B6J mice harbor Nnt and Nlrp12 mutations, and hepatic NNT re-expression mitigated weight loss, with a trend toward reduced GDF15. An Nrp12 knockout (KO) in B6NJ mice induced weight loss and increased LCN2, and combined Nlrp12/Nnt KO shifted the response to KD-5%P toward that of B6J mice. Finally, in B6J mice, KD-5%P induced hepatic stress and inflammation, and N-acetylcysteine reduced circulating GDF15 and LCN2 to attenuate weight loss. These findings indicate that interactions between macronutrient composition and genetic background shape the murine response to a low-protein KD, suggesting that these factors might also be relevant to the response in humans.
    Keywords:  GDF15; LCN2; Nlrp12; Nnt; genetic background; inflammation; ketogenic diet; metabolic adaptation; oxidative stress
    DOI:  https://doi.org/10.1016/j.cmet.2026.10.017
  10. J Lipid Res. 2026 Nov 16. pii: S0022-2275(26)00222-1. [Epub ahead of print] 101192
      We investigated the impact of cell culture medium composition on lipogenesis in vitro using the 3T3-L1 adipocyte cell line, a highly lipogenic model derived from murine adipose stromovascular cells. Compared with murine adipose tissue, 3T3-L1 adipocytes exhibit elevated odd-chain fatty acids (OCFAs) and reduced fatty-acid chain length. This fatty acid profile of 3T3-L1 adipocytes points towards the limitations of its standard culture in DMEM, which lacks certain nutrients, such as vitamins B7 (biotin) and B12 (cobalamin), which are essential for supporting metabolic pathways that feed lipogenesis. Using stable isotope tracing, we probed lipid synthesis rates and desaturation of fatty acid elongation. We demonstrated that both biotin and cobalamin are required to fully eliminate OCFA production. Supplementation with biotin or cobalamin alone lowered OCFAs by approximately 50%, while combined supplementation reduced OCFAs by 95%. Residual OCFAs were shown to arise from α-oxidation. The effects of biotin and cobalamin on OCFA synthesis reflect their roles as cofactors for propionyl-CoA carboxylase and methylmalonyl-CoA mutase, respectively. We further examined other vitamin-dependent enzymes and found that biotin supplementation increased activity of acetyl-CoA carboxylase 1 and methylcrotonyl-CoA carboxylase, whereas pyruvate carboxylase activity was unaffected, likely due to sufficient biotin derived from serum. Although vitamin supplementation normalised OCFA abundance, it did not restore fatty acid chain length, however we determined that endogenous and exogenous palmitate were differentially elongated, identifying a novel regulatory step for fatty acid composition. Overall, these findings underscore the critical influence of cell culture medium composition on lipid metabolism in vitro.
    Keywords:  3T3-L1 adipocyte; B12; B7; biotin; cobalamin; culture media; deuterated water; fatty acid; mass spectrometry; replacement
    DOI:  https://doi.org/10.1016/j.jlr.2026.101192
  11. Sci Adv. 2026 Nov 20. 12(47): eaee0620
      Local protein synthesis in axons and dendrites underpins synaptic plasticity. However, the composition of the protein synthesis machinery in distal neuronal processes and the mechanisms for its deployment to local translation sites remain unclear. Here, we employed multi-scale imaging that combines cryo-electron tomography, volume electron microscopy, and live-cell imaging to identify endoplasmic reticulum-derived KDEL-positive vesicles, a subset of which are decorated with ribosomes (Ribosome-Associated Vesicles, RAVs) in neurites. We demonstrate that neuronal stimulation triggers compartment-specific responses: dendrites accumulate stationary KDEL-positive vesicles at sites of enhanced translation, while axons accelerate vesicle transport. cLTP stimulation additionally increases the proportion of KDEL-positive vesicles that carry ribosomes, expanding the local RAV pool. Real-time imaging of translation at single mRNA resolution reveals that RAV-associated translation sites exhibit ∼30% greater nascent-peptide signal amplitude compared to periods without RAV association, indicating that RAVs boost local translation output. These findings establish RAVs as specialized platforms that integrate activity-dependent signals with local protein synthesis, providing a mechanistic framework for understanding how neurons achieve precise spatiotemporal control of translation.
    DOI:  https://doi.org/10.1126/sciadv.aee0620
  12. bioRxiv. 2025 Nov 03. pii: 2025.11.01.686055. [Epub ahead of print]
      The tumor microenvironment (TME) programs cancer cells to influence therapeutic responses. Macrophages residing in TME switch from pro-phagocytic to tumor-promoting and immunosuppressive phenotypes as cancer develops. While these pro-tumor functions of macrophages are associated with poor outcomes, the underlying mechanisms by which bone-marrow (BM)-associated macrophages fuel myeloid malignancy and their precise contribution to relapse remain undissected. Here, we show expansion of monocyte/macrophage population in leukemia patients post-chemotherapy relapse, and spatial proximity of macrophages to leukemia blasts in the BM niche. This proximity proved functionally consequential-depletion of macrophages delayed leukemia relapse post cytarabine (AraC), a frontline chemotherapy, in patient-derived xenografts (PDX) and syngeneic leukemia models. Mechanistically, a pyrimidine metabolite, deoxycytidine (dC), secreted by BM macrophages, is taken up by leukemia cells to directly inhibit deoxycytidine kinase (DCK) to hamper AraC activation and subsequent resistance in a cell non-autonomous manner. Diagnosis AML patients exhibited significantly higher circulating dC levels than healthy donors, and dC levels further increased following chemotherapy. SAMHD1, which catalyzes deoxynucleoside triphosphates (dNTPs) into deoxynucleoside, was highly abundant in macrophages and mediated dC accumulation. Blockade of dC production in mouse and human macrophages via genetic and pharmacological inhibition of SAMHD1 or DHODH , a critical enzyme in pyrimidine synthesis, restored AraC sensitivity. Combination with DHODH inhibitors significantly delayed AraC relapse in human PDX and mouse syngeneic AML models. Collectively, we identify a metabolic immune-leukemia crosstalk in which SAMHD1 high macrophages mediates chemoresistance by secreting pyrimidine metabolites and propose macrophage metabolic reprogramming as a tractable strategy to overcome TME-driven chemoresistance in myeloid leukemia.
    DOI:  https://doi.org/10.1101/2025.11.01.686055
  13. Blood Red Cells Iron. 2026 Sep;2(3): 100091
      Sickle cell disease (SCD) is characterized by chronic hemolysis and excess free heme, which drive oxidative stress, inflammation, and progressive organ damage. Although the pathological consequences of heme are well recognized, its direct impact on erythroid metabolism and epigenetic regulation remains incompletely understood. Here, we demonstrate that excess heme acts as a central metabolic-epigenetic disruptor in sickle erythroblasts, triggering ferroptosis through coordinated suppression of glutamine metabolism and mitochondrial function. Hemin exposure induced robust lipid peroxidation and ferroptotic cell death, accompanied by impaired cystine uptake, glutathione depletion, and increased ferroptosis markers. Mechanistically, heme selectively repressed the catalytically active glutaminase (GLS) isoform GLS type C, leading to reduced intracellular glutamate availability and compromised redox homeostasis. At the epigenetic level, heme promoted global histone hypermethylation and chromatin compaction at genes governing glutamine and glutamate metabolism. This effect was driven by mitochondrial dysfunction and disruption of the oxoglutarate dehydrogenase complex, resulting in the accumulation of l-2-hydroxyglutarate, a potent inhibitor of α-ketoglutarate-dependent histone demethylases. Stable isotope tracing confirmed enhanced glutamine flux toward 2-oxoglutarate and l-2-hydroxyglutarate under heme stress. Importantly, supplementation with the cell-permeable α-ketoglutarate analog dimethyl α-ketoglutarate restored tricarboxylic acid cycle activity, reduced histone hypermethylation, rescued GLS expression, replenished glutathione, and alleviated heme-induced ferroptosis. Together, these findings uncover a previously unrecognized metabolic-epigenetic circuit linking excess heme to mitochondrial dysfunction, chromatin remodeling, and ferroptosis in sickle erythropoiesis and identify metabolic repletion strategies as potential therapeutic treatment approaches for SCD.
    DOI:  https://doi.org/10.1016/j.brci.2026.100091
  14. Nat Commun. 2026 10 16. pii: 11684. [Epub ahead of print]17(1):
      A fundamental challenge in human genetics is determining how regulatory genetic variation shapes complex traits and disease risk. Chromatin quantitative trait loci can link disease-associated variants to regulatory element activity, but mapping them in disease-relevant tissues at scale remains challenging. We leverage epigenomic liquid biopsy by profiling histone modifications in circulating chromatin from 328 cancer patients and 38 healthy individuals to identify cell-free chromatin quantitative trait loci. These loci affect regulatory element activities from diverse non-hematologic tissues and developmentally restricted elements reactivated in cancer. Through cistrome-wide association studies, we link 4891 loci to 1011 traits and diseases. Developmentally restricted loci absent in white blood cells are associated with 22.7 traits per 100 quantitative trait loci, compared to 0.58 for white-blood-cell-restricted chromatin quantitative trait loci. Here, we show that cell-free chromatin enables efficient and scalable discovery of regulatory genetic effects across tissues, diseases, and populations.
    DOI:  https://doi.org/10.1038/s41467-026-78569-8
  15. Cell Metab. 2026 Nov 16. pii: S1550-4131(26)00453-5. [Epub ahead of print]
      Interventions such as caloric restriction and time-restricted feeding improve lifespan and aging-associated metabolic health, in part through effects on the gut microbiome and bile acid dynamics. However, how aging alters microbial function and bile acid signaling, and whether these changes can be therapeutically leveraged, remain unclear. Here, we show that aged mice exhibit increased deconjugation of taurine-conjugated bile acids accompanied by increased bile salt hydrolase (BSH)-related transcriptional activity. Individuals with exceptional longevity show a similar bile acid deconjugation signature, suggesting an association with resilient or exceptional aging. Using engineered native bacteria, we further increased luminal BSH activity in aged mice and improved insulin sensitivity, accompanied by supportive changes in body composition and other metabolic readouts. Together, these findings suggest that elevated BSH activity may have a protective role during aging. They challenge the view that age-related changes in bile acid biotransformations are uniformly detrimental, highlighting microbial bile acid modulation as a potential strategy to improve late-life metabolic health.
    Keywords:  NF-κ B signaling; bacterial engraftment; centenarian; circadian rhythms; host-microbe interactions; ileum; insulin resistance; metatranscriptomics; mitochondrial respiration; respiratory exchange ratio
    DOI:  https://doi.org/10.1016/j.cmet.2026.10.016
  16. Int J Biol Macromol. 2026 Nov 16. pii: S0141-8130(26)05274-8. [Epub ahead of print] 155320
      Beyond their roles as substrates for protein synthesis, amino acids serve as potent signaling molecules that convey nutrient availability to the mechanistic target of rapamycin complex 1 (mTORC1), a central regulator of cellular growth, metabolism, and autophagy. This nutrient-dependent regulation relies on a diverse network of sensors distributed across extracellular, cytosolic, and lysosomal compartments. Despite their mechanistic diversity, these pathways converge on the GATOR-Rag GTPase axis to dictate the lysosomal recruitment and activation of mTORC1. Here, we propose a conceptual framework that organizes amino acid sensors according to their subcellular localization, modes of nutrient recognition, and signaling outputs, categorizing them into direct metabolite-binding sensors, stress-responsive sensors, and enzymatic sensors. Drawing on recent structural, biochemical, and physiological insights, this review contrasts how these disparate sensors modulate mTORC1 activity and examines the principles governing multi-nutrient integration. Furthermore, we evaluate the pathological implications of dysregulated amino acid sensing in cancer, metabolic diseases, and neurological and neuropsychiatric disorders. Finally, we highlight recent advances in pharmacologically targeting amino acid-sensing pathways, particularly the modulation of Sestrin-dependent leucine sensing as an emerging strategy for depression.
    Keywords:  Amino acid sensing; CASTOR; Rag GTPase; SAMTOR; Sestrin; mTORC1
    DOI:  https://doi.org/10.1016/j.ijbiomac.2026.155320
  17. Res Sq. 2026 Nov 05. pii: rs.3.rs-10911194. [Epub ahead of print]
      Single-cell spatial transcriptomics is now central to studying tumors in their native tissue context. Here we present the first comprehensive, independent evaluation of Atera, a new spatial whole-transcriptome platform, compared with Xenium in human ductal carcinoma in situ (DCIS). We show that Atera enables granular cell-state annotation and resolves rare cell populations, experimentally validated by multiplex immunofluorescence (IF). We further show that its transcriptome-wide coverage enables inference of copy-number alterations at single-cell resolution, allowing us to reconstruct the clonal evolution of DCIS. We orthogonally confirm the inferred copy-number alterations by whole-genome sequencing of 16 microdissected tumor regions from consecutive tissue sections. Finally, by mapping the immune microenvironment onto this clonal architecture, we demonstrate the feasibility of tracking the changes in immune response along the clonal tumor evolution in situ. Together, our results establish Atera as a validated platform for tracking clonal evolution and immune adaptation in clinical samples.
    DOI:  https://doi.org/10.21203/rs.3.rs-10911194/v1
  18. Nat Methods. 2026 Nov 19.
      Metastases arise when cancer cells disseminate from the primary tumor, or other metastases, and seed tumors at distant anatomical sites. Reconstructing migration histories from DNA sequencing data is key to understanding the cellular mechanisms underlying metastatic dissemination. While the data often support many equally plausible histories, current methods return a single solution or sample alternatives without guarantees of optimality or completeness. Here we introduce MACH2, which enumerates all optimal migration histories and summarizes them to identify high-confidence migrations. MACH2 combines existing parsimony criteria with a new criterion that minimizes the number of clones assigned to locations where they were not observed, and includes MACH2-viz, an interactive tool for exploring solutions. Using simulated tumors with known ground truth, we show that MACH2 outperforms existing methods. Across 145 lung, ovarian, breast and prostate cancers, MACH2 reveals extensive uncertainty in migration histories, infers histories consistent with orthogonal experimental data, and finds metastasis-to-metastasis seeding and linear progression to be common.
    DOI:  https://doi.org/10.1038/s41592-026-03321-5
  19. J Biol Chem. 2026 Nov 16. pii: S0021-9258(26)02632-3. [Epub ahead of print] 113760
      Barth syndrome is a life-threatening genetic disorder caused by mutations in the TAFAZZIN (TAZ) gene, which disrupt remodeling of cardiolipin in mitochondria. The disease is associated with cardiac and skeletal myopathy, neutropenia, fatigue, and metabolic dysfunction. Previous studies showed that loss of TAZ decreases pyruvate dehydrogenase activity, reduces glucose flux into the TCA cycle, and impairs fatty acid metabolism. To test the hypothesis that amino acid (AA) metabolism may be altered to compensate for these deficiencies, we characterized AA metabolism in TAZ-deficient mouse myoblasts (TAZ-KO). Levels of branched-chain amino acids (BCAAs) were reduced, while proline levels were increased in TAZ-KO cells. Levels of proline dehydrogenase and glutamate dehydrogenase, which convert proline to TCA cycle intermediates, were increased. 13C5-proline isotope tracing demonstrated elevated conversion of proline into glutamate and TCA cycle intermediates. SILAC analysis using [U-13C6, 15N2]-Lys and [U-13C6]-Arg revealed decreased synthesis of collagen and proteins associated with extracellular matrix (ECM). Gene expression and protein analyses revealed reduced collagen expression, lower total collagen content, decreased collagen crosslinking enzymes, decreased proline hydroxylation and reduced synthesis of new collagen and cell-adhesion proteins. SILAC analysis using [U-13C5]-proline also showed diminished incorporation of proline into newly synthesized ECM proteins. Together, our findings reveal that loss of TAZ leads to increased proline catabolism to the TCA cycle, decreased incorporation of proline into collagen, and impaired collagen synthesis and ECM remodeling.
    Keywords:  Barth syndrome; SILAC; TAFAZZIN; amino acid metabolism; collagen; extracellular matrix
    DOI:  https://doi.org/10.1016/j.jbc.2026.113760
  20. Trends Endocrinol Metab. 2026 Nov 18. pii: S1043-2760(26)00295-X. [Epub ahead of print]
      Acetyl-coenzyme A (acetyl-CoA) is an essential metabolite that integrates carbon metabolism with cellular function. As a metabolic substrate and acetyl-group donor, acetyl-CoA supports energy production and biosynthesis and links nutrient status to epigenetic regulation through spatially and temporally regulated acetylation. In this review, we discuss the metabolic sources and compartmentalization of acetyl-CoA, its canonical roles in energy metabolism and biosynthesis, and emerging mechanisms by which acetyl-CoA functions as a signaling metabolite. We further highlight recent evidence that cytosolic acetyl-CoA is directly sensed by nucleotide-binding oligomerization domain-like receptor family member X1 to regulate mitophagy and discuss unanswered questions regarding acetyl-CoA sensing and signaling.
    Keywords:  acetyl-coenzyme A; compartmentalization; mitophagy; sensing; signaling metabolite
    DOI:  https://doi.org/10.1016/j.tem.2026.10.006
  21. Sci Adv. 2026 Nov 20. 12(47): eael2126
      Mitochondria transplantation is a proposed therapeutic approach to improve the function of diseased or injured tissue. It has garnered attention and sparked debate.
    DOI:  https://doi.org/10.1126/sciadv.ael2126
  22. Kidney Int. 2026 Nov 18. pii: S0085-2538(26)00942-7. [Epub ahead of print]
       INTRODUCTION: Clear cell renal cell carcinoma (ccRCC), the most common subtype of RCC, is characterized by constitutive activation of hypoxia-inducible factors (HIF-1α and HIF-2α), with HIF-2α promoting peroxisome turnover. Although peroxisomes play key roles in lipid metabolism and reactive oxygen species homeostasis, they remain relatively understudied in cancer research, and their contribution to ccRCC is poorly understood. Notably, peroxisome abundance is more frequently reduced in low-grade than in high-grade tumors, suggesting a potential role in tumorigenesis.
    METHODS: Peroxisome depletion was induced by impairing peroxisome biogenesis and by inducing pexophagy. Tumor growth was evaluated in subcutaneous xenograft models. Multi-omics analyses, including transcriptomics, proteomics, metabolomics, and lipid profiling, were performed on tumor tissues. Cellular metabolism was assessed using Seahorse extracellular flux analysis in spheroids cultured in human plasma-like medium. Changes in the tumor microenvironment (TME) were evaluated by histological analysis.
    RESULTS: Peroxisome depletion significantly suppressed ccRCC progression by reducing tumor cell proliferation. It impaired mitochondrial fitness, particularly oxidative phosphorylation, the tricarboxylic acid cycle, and mitochondrial translation. These changes were accompanied by reductions in both glycolytic and mitochondrial flux, resulting in decreased metabolic flexibility and a shift toward a quiescent bioenergetic state that limits tumor growth. Peroxisome-depleted tumors also exhibited oxylipin accumulation. Moreover, peroxisome loss reshaped the TME, as evidenced by increased collagen deposition, enhanced stromal cell infiltration, and a shift in fibroblast populations toward SERPINH1-positive (Serpin Family H Member 1) phenotypes. Consistently, low peroxisome abundance was associated with increased fibrosis in human ccRCC samples.
    CONCLUSIONS: Peroxisome loss constrains ccRCC progression through coordinated metabolic and microenvironmental alterations. These findings highlight a previously underappreciated role of peroxisomes in regulating metabolic fitness and the TME in ccRCC, and suggest potential therapeutic strategies aimed at targeting peroxisome homeostasis in kidney malignancies.
    Keywords:  OXPHOS; ccRCC; fibrosis; mitochondria; oxylipins; pexophagy
    DOI:  https://doi.org/10.1016/j.kint.2026.10.028
  23. bioRxiv. 2026 Nov 12. pii: 2026.11.10.765195. [Epub ahead of print]
      Müller glia regenerate retinal neurons after injury in zebrafish, but how their mitochondrial organization changes during regenerative activation remains poorly defined. Here, we combined mitochondrial imaging, Müller glial transcriptomics, and whole eyecup metabolomics to investigate the response to selective photoreceptor loss. A Müller glia mitochondrial reporter revealed spatial and temporal mitochondrial remodeling: morphological changes were detectable in inner retinal compartments before sustained increases in mitochondrial volume emerged in processes adjacent to injured photoreceptors. This response coincided with reduced respiratory chain transcript expression and selective induction of mitochondrial assembly and maintenance genes, while the eyecup underwent temporally patterned metabolic changes. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinases (PDK), attenuated outer-retinal Müller glial mitochondrial remodeling. DCA also reshaped the Müller glial transcriptional response to injury, suppressing reprogramming- and cell-cycle-associated programs and altering metabolic and mitochondrial gene expression. DCA treatment also blocked the formation of tuba1a :GFP + Müller glia and PCNA expression, indicating that reprogramming and progenitor proliferation requires PDK activity. Together, our findings identify compartment-specific mitochondrial remodeling as an early event in the Müller glial regenerative response and demonstrate that mitochondrial remodeling and regenerative activation are sensitive to perturbation of the PDK-PDH regulatory axis.
    Significance Statement: Zebrafish Müller glia can generate progenitors that replace injured retinal neurons, but how their mitochondria reorganize during this transition remains poorly understood. We show that localized photoreceptor loss elicits mitochondrial remodeling across Müller glial compartments, with distinct temporal responses that accompany selective mitochondrial gene regulation and tissue-level metabolic changes. Inhibiting pyruvate dehydrogenase kinases attenuates outer-retinal mitochondrial remodeling and markedly reduces reprogramming-associated and proliferative responses. These findings identify spatial mitochondrial organization as a component of regenerative glial activation and establish a framework for investigating how metabolic regulation influences endogenous retinal repair.
    DOI:  https://doi.org/10.64898/2026.11.10.765195
  24. bioRxiv. 2026 Nov 04. pii: 2026.11.03.763985. [Epub ahead of print]
      Cysteine is essential for life but toxic in excess. Cells and tissues are exposed to elevated cysteine from endogenous sources and the environment yet maintain low intracellular concentrations to sustain life. Here we identify a mechanism for sensing cysteine to control its abundance and prevent toxicity and premature death. Using cryo-electron microscopy we determine structures of the CRL5 LRRC58 E3 ligase alone and in complex with the cysteine-catabolizing enzyme CDO1. We show that CDO1 interacts with LRRC58 in the vicinity of a zinc-coordinating cysteine motif, within which Cys296 becomes covalently modified upon cysteine exposure. Covalent modification of Cys296 and zinc ejection from this motif drive large structural rearrangements of LRRC58 relayed through Cys319, which destabilize CDO1 binding and position LRRC58 Lys111 for autoubiquitylation. This reorientation of LRRC58 permits CDO1 accumulation, thereby lowering intracellular cysteine. Mutation of Cys319 abrogates inhibitory rearrangement of LRRC58 upon cysteine modification. This renders the ligase constitutively active and prevents CDO1 stabilization, thereby driving systemic cysteine accumulation and premature death in animals. These findings establish the molecular basis of homeostatic cysteine sensing by LRRC58 and demonstrate its essential role in maintaining cysteine concentrations compatible with healthy life.
    DOI:  https://doi.org/10.64898/2026.11.03.763985
  25. bioRxiv. 2026 Nov 06. pii: 2026.11.05.764693. [Epub ahead of print]
      Somatic mutations in isocitrate dehydrogenase 1 (IDH1) define major subtypes of adult diffuse gliomas and occur across a broad spectrum of cancers. These mutations ablate the conventional turnover of isocitrate to alpha-ketoglutarate and confer the neomorphic production of D -2-hydroxyglutarate (D2HG), which drives epigenetic remodeling. Growing evidence suggests this neomorphic activity may also affect how tumor cells communicate; small extracellular vesicles (sEVs) are elevated in gliomas, though how mutant IDH1 shapes sEV production and cargo remains poorly understood. Using glioblastoma and chondrosarcoma cell models, we show expression of mutant IDH1 correlates with a trend of increased sEV secretion, and that D2HG is packaged into sEVs that are taken up by cells. Cell-permeable D2HG treatment dose-dependently increased sEV release from IDH1 wild type cells. Untargeted proteomics showed that mutant IDH1 expression remodeled sEV cargo in a cell type-specific fashion, with mutant chondrosarcoma sEVs enriched in one-carbon metabolism enzymes, and mutant glioma sEVs in lysosomal luminal proteins and endoplasmic reticulum (ER) chaperones. Mutant IDH1 glioma cell transcriptomics suggested expanded ER folding capacity and reduced ribosomal pathways, and sEVs from these cells decreased nascent protein synthesis in IDH1 wild type recipient cells. Together, this suggests sEVs can serve as carriers of mutant IDH1 phenotypes.
    DOI:  https://doi.org/10.64898/2026.11.05.764693
  26. Nat Commun. 2026 Oct 23. pii: 11867. [Epub ahead of print]17(1):
      Gametogenesis rejuvenates the cellular lineage and excludes senescence-associated factors from gametes. In Saccharomyces cerevisiae, this involves sequestration of nuclear constituents into the Gametogenesis Uninherited Nuclear Compartment (GUNC), which is excluded from gametes. Here we identify the conserved mitochondrial import receptor Tom70 as a key regulator of GUNC-mediated exclusion. Loss of TOM70 disrupts the sequestration of nuclear pore complexes, but not senescence-associated aggregates and nucleolar components, into the GUNC. Tom70's role appears independent of its canonical function in mitochondrial import and instead reflects a meiosis-specific requirement for mitochondria-nuclear envelope tethering. During meiosis II, Tom70 concentrates around the GUNC, where it recruits the nuclear envelope tethering protein Cnm1. Loss of CNM1 partially phenocopies tom70∆, consistent with parallel tethering interactions. These findings uncover a previously unrecognized organelle contact-dependent pathway that remodels the nuclear envelope to support selective nuclear inheritance. More broadly, they highlight how organelle contacts integrate with nuclear quality control to safeguard gamete integrity.
    DOI:  https://doi.org/10.1038/s41467-026-78562-1
  27. Nat Commun. 2026 Oct 20. pii: 11803. [Epub ahead of print]17(1):
      As solid tumors progress, the tumor microenvironment becomes increasingly immunosuppressive, impairing cytotoxic T-cell activity and limiting the efficacy of immune checkpoint blockade. However, the mechanistic drivers of this immunosuppression remain poorly understood. Here, we identify a tumor-derived lipid-neutrophil-adenosine axis as a critical regulator of immune suppression in advanced colorectal cancer (CRC). We show that fatty acids enriched in tumor interstitial fluid reprogram neutrophils toward an immunosuppressive phenotype through PPARα activation, upregulation of CD39 and CD73, and adenosine generation, ultimately leading to T-cell suppression. AB928, a dual A2aR/A2bR adenosine receptor antagonist currently in clinical trials, restores T-cell proliferation, effector function, and tumor-killing capacity in vitro and in vivo. Importantly, AB928 synergizes with anti-PD-1 therapy to enhance survival in an immunotherapy-resistant autochthonous model of metastatic CRC. Thus, our findings define a metabolic immune evasion mechanism in the microenvironment and provide a rationale for targeting neutrophil-derived adenosine signaling to improve immunotherapy responses in CRC.
    DOI:  https://doi.org/10.1038/s41467-026-78771-8
  28. J Clin Invest. 2026 Nov 19. pii: e207965. [Epub ahead of print]
      Mitochondrial failure is a convergent driver of neuronal aging and neurodegeneration, yet upstream factors that link age-associated changes to mitochondrial homeostasis remain incompletely defined. Melatonin, which is synthesized within neuronal mitochondria, declines with age and is further exacerbated in several neurodegenerative disorders. Here we show that endogenous melatonin is required to maintain cerebral mitochondrial biogenesis and mitochondrial quality through the SIRT1/PGC-1α signaling axis. Across young (8-week), adult (20-week), and middle-aged (1-year) mouse brains, aging was associated with reduced SIRT1/PGC-1α, decreased mtDNA copy number, and diminished abundance of oxidative phosphorylation proteins. Human hippocampal samples from older donors similarly exhibited reduced SIRT1/PGC-1α but retained mitochondrial protein abundance while accumulating oxidatively damaged mitochondria and showing reduced LC3B, consistent with impaired mitochondrial quality control. In aralkylamine N-acetyltransferase knockout (AANAT-KO) mice, endogenous melatonin deficiency suppressed SIRT1/PGC-1α, NRF1, and TFAM in an age-dependent manner, reduced mtDNA and mitochondrial transcript abundance, lowered mitochondrial protein levels, and increased mitochondrial oxidative damage. Melatonin supplementation restored the biogenesis program, increased mtDNA and mitochondrial transcripts, and rescued respiratory chain protein abundance. Finally, mitochondrial transplantation experiments indicated that mitochondrial quality contributes to neuronal integrity. Melatonin-deficient mitochondria induced neurite degeneration in wild-type neurons, whereas wild-type mitochondria rescued neurite architecture and improved survival in melatonin-deficient neurons. Together, these findings identify endogenous melatonin as a regulator of cerebral mitochondrial biogenesis and suggest that melatonin decline contributes to mitochondrial-mediated neuritic degeneration and neuronal loss.
    Keywords:  Aging; Mitochondria; Neurodegeneration; Neuroscience
    DOI:  https://doi.org/10.1172/JCI207965
  29. Proc Natl Acad Sci U S A. 2026 Nov 24. 123(47): e2604077123
      Microtubule (MT) acetylation is frequently elevated in cancer and associated with poor prognosis. Alpha-tubulin acetyltransferase 1 (ATAT1), the principal enzyme responsible for this modification, has therefore emerged as a potential therapeutic target. However, which cancer types depend on ATAT1 activity and are selectively vulnerable to its inhibition remains unclear. Here, using a phospho-specific marker of ATAT1 activity, we identify pancreatic ductal adenocarcinoma (PDAC) as an ATAT1-dependent malignancy. ATAT1 activity is elevated in human PDAC and genetically engineered mouse models, emerging during pancreatic intraepithelial neoplasia and persisting in a substantial subset of tumors. Genetic inactivation or pharmacologic inhibition of ATAT1 suppresses PDAC cell growth, reduces orthotopic tumor burden, and markedly inhibits tumor initiation in KPC mice without overt toxicity. Mechanistically, ATAT1-dependent MT acetylation sustains Akt signaling, resulting in inhibitory phosphorylation of GSK3β and stabilization of the DNA methyltransferase DNA methyltransferase 1 (DNMT1). Elevated DNMT1 promotes repression of tumor suppressor genes, including NDRG4, whereas inhibition of ATAT1 or DNMT1 restores NDRG4 expression and impairs tumor growth. Together, these findings identify a previously unrecognized ATAT1-Akt-GSK3β-DNMT1 signaling axis linking cytoskeletal acetylation to NDRG4 repression and reveal ATAT1 as a therapeutic vulnerability during the early stages of pancreatic tumorigenesis.
    Keywords:  ATAT1; PDAC; microtubules; proteomics
    DOI:  https://doi.org/10.1073/pnas.2604077123
  30. Genome Biol. 2026 Aug 27. pii: 366. [Epub ahead of print]27(1):
       BACKGROUND: Mitochondrial DNA (mtDNA) mutations cause multisystem disorders often involving gastrointestinal dysfunction. However, the mechanisms governing the selection against mutant mtDNA and the specific impact of pathogenic mtDNA mutations on intestinal epithelial cells (IECs) remain poorly understood. Here, we employed mitochondrial single-cell assay for transposase-accessible chromatin with sequencing (mtscATAC-seq) to profile heteroplasmy dynamics in nine subtypes of IECs in m.G5081A (mt-tRNA) and m.G12918A (mt-mRNA) mutant mouse models over a two-year lifespan.
    RESULTS: Our findings reveal an age-dependent decline in mtDNA mutation in all IECs, a process originating within the intestinal stem cell compartment. Integrating single-cell RNA sequencing data, we observe that young mice harboring high m.G5081A mutation loads exhibit profound IEC dysfunction, characterized by impaired enterocyte differentiation and defective Paneth cell granule formation. Furthermore, m.G5081A mice display increased susceptibility to dextran sulfate sodium induced acute colitis, attributed to impaired intestinal barrier restoration driven by mitochondrial dysfunction.
    CONCLUSIONS: Collectively, our study elucidates the heteroplasmy dynamics of mtDNA mutations in IECs during aging and demonstrates the functional consequences of mitochondrial defects on intestinal health, offering critical insights into the pathogenesis and potential management of mitochondrial diseases.
    Keywords:  Colitis; Intestine; Mitochondria; Selection; Single-cells
    DOI:  https://doi.org/10.1186/s13059-026-04256-y
  31. Science. 2026 Nov 19. 394(6826): eaee8018
      Although RNA quality control tightly regulates gene expression, the scope of its regulatory functions in the nucleus remains unclear. In this study, we describe the quality control, on chromatin, of poised intron-containing polyadenylated RNAs (PIA-RNAs). Whether these precursor messenger RNAs (pre-mRNAs) constitute immature mRNAs whose splicing is pending or, alternatively, are degraded by the nuclear RNA exosome depends on whether they engage nuclear cap-binding protein 3 (NCBP3) or anillin, respectively. Many PIA-RNAs inversely controlled by NCBP3 and anillin encode mitochondrial factors. Thus, NCBP3 depletion in mouse as well as pathogenic mutations in the RNA exosome in humans result in reduced mitochondrial activity, muscle weakness, cerebellar hypomyelination, and diminished motor coordination. Our findings reveal a competition between pre-mRNA metabolic pathways whose balance controls mitochondrial function and, when perturbed, leads to neurological diseases.
    DOI:  https://doi.org/10.1126/science.aee8018
  32. bioRxiv. 2026 Nov 09. pii: 2026.11.06.764901. [Epub ahead of print]
      Melanoma arises when melanocytes are oncogenically reprogrammed into neural crest-like cells, but what initiates this switch is unknown. Here we show that endogenous retrovirus (ERV)-derived double stranded RNAs (dsRNAs) induce stress granules (SGs) that drive this fate change. In zebrafish, melanoma progresses through a stage-specific ERV switch: zferv marks precursor cells before crestin activates in tumor cells. Both elements generate dsRNA that triggers eif2ak2 -dependent SGs within precursor lesions and through transformation. SGs are tumorigenic as G3BP1 overexpression accelerates melanoma onset, whereas mosaic, melanocyte-specific g3bp1/2 knockout delays it. Small molecule-mediated inhibition of G3BP1/2 eliminates precursor lesions and reduces tumor burden. Similarly, blocking dsRNA sensing prevents SG formation and lowers melanoma incidence. Human nevi and melanomas show analogous, stage-specific ERV programs and SG assembly. In human melanoma cells, SGs sequester and translationally repress SOX10-regulating mRNAs, including the tumor suppressor KMT2D . Mosaic knockout of kmt2d in vivo enhances SOX10-driven neural crest reactivation. Thus, an ERV-SG axis establishes an oncogenic translatome that enables melanoma fate, with diagnostic and therapeutic potential.
    DOI:  https://doi.org/10.64898/2026.11.06.764901
  33. J Clin Invest. 2026 Nov 19. pii: e206802. [Epub ahead of print]
      Through a genome-wide forward CRISPR/Cas9 screen in interleukin-3 (IL3)-dependent Ba/F3 cells, we identified osteoclastogenesis-associated transmembrane protein 1 (OSTM1) as a previously unrecognized tumor suppressor. Analysis of patient datasets revealed that OSTM1 is frequently deleted or downregulated in human B-cell malignancies (BCM). In mice, Cd19-Cre-driven B cell-specific monoallelic or biallelic deletion of Ostm1 cooperated with Cdkn2a loss to drive lymphomagenesis with near-complete penetrance. Mechanistically, OSTM1 directly interacts with phosphodiesterase 3B (PDE3B) and promotes its proteasomal degradation. Because PDE3B hydrolyzes cyclic AMP (cAMP), loss of OSTM1 stabilizes PDE3B, leading to suppression of tumor-suppressive cAMP-dependent PKA/CREB signaling and promotion of oncogenic transformation. Consistent with this mechanism, PDE3B is frequently amplified or upregulated in BCM, and expression of CREB/CREBBP transcriptional targets correlates positively with OSTM1 expression but inversely with PDE3B across BCM cohorts. Importantly, silencing Pde3b reverses oncogenic transformation driven by Ostm1 loss. Together, these findings establish OSTM1 as a tumor suppressor and uncover an OSTM1/PDE3B/cAMP signaling axis that restrains B-cell lymphomagenesis and may represent a therapeutically actionable vulnerability.
    Keywords:  B cells; Cell biology; Lymphomas; Oncology; Tumor suppressors
    DOI:  https://doi.org/10.1172/JCI206802
  34. J Am Chem Soc. 2026 Nov 18. 148(45): 48720-48736
      Metabolic theories for the origin of life postulate that chemical reaction networks emerged spontaneously from geochemistry and grew more complex due to positive feedback effects in catalysis. However, experimentally establishing protometabolic networks has proven challenging. In this Perspective, we make the case for electric field catalysis at charged aqueous interfaces as a crucial overlooked element for initiating protometabolic networks, an initial constraint that foreshadows the eventual takeover of electrostatic catalysis by enzymes. We first overview types of positive feedback relevant to the early evolution of metabolism, the theory of electric field catalysis, and its dominant role in enzyme catalysis. We then examine recent experiments and calculations highlighting the ability of external electric fields to enable nonenzymatic analogues of challenging metabolic reactions in micro- to millisecond reaction times. An underexplored mode of small molecule catalysis (reorientation catalysis) that can only operate in external electric fields is proposed to make positive feedback within prebiotic reaction networks more achievable. By embodying electrostatic catalysis, compartmentalization, and ion concentration gradients, charged aqueous interfaces prepattern three fundamental features of biology, making them a preferred environment for a metabolic origin of life. Making robust progress on the origin of life may surprisingly require exploring the nascent area of electric field-mediated chemistry at aqueous interfaces. Life does not use electric fields to catalyze its metabolic network by accident.
    DOI:  https://doi.org/10.1021/jacs.6c15198
  35. Nat Commun. 2026 Oct 20. pii: 11788. [Epub ahead of print]17(1):
      Metabolic dysregulation under nutrient stress disrupts bone homeostasis. Although acetate metabolism is linked to diabetes and alcoholism, its role in the skeletal complications of these conditions remains unknown. Here we identify acetyl-CoA synthetase 1 (ACSS1) as a key stress responder that mediates mitonuclear communication in bone marrow skeletal stem cells. ACSS1-driven rewiring of acetate metabolism impairs cellular metabolic flexibility, mitochondrial function, and osteogenesis. Mechanistically, nutrient excess from glucose, alcohol or acetate upregulates ACSS1 via a mitochondrial ROS activated integrated stress response-CEBPB pathway. Maladaptive ACSS1 accumulation enforces excessive acetyl-CoA production from either exogenous or glucose/ethanol-derived endogenous acetate, promoting mitochondrial protein hyperacetylation specifically inactivating ME2 via lysine 94 acetylation. This ACSS1-triggered ME2 inactivation disturbs the malate-aspartate shuttle, leading to a self-perpetuating cycle of redox imbalance and oxidative stress that exacerbates mitochondrial dysfunction and osteogenic impairment. Importantly, genetic deletion of Acss1 or AAV-delivered non-acetylatable ME2 mutant in osteoprogenitor cells restores mitochondrial resilience, osteogenic capacity, and bone formation, protecting against osteoporosis or osteonecrosis in male mouse models of type 2 diabetes and chronic alcohol consumption. These results unveil an essential role for ACSS1 in controlling metabolic flexibility and osteogenesis, identifying ACSS1 as a potential therapeutic target for metabolic stress-related bone disorders.
    DOI:  https://doi.org/10.1038/s41467-026-77684-w
  36. bioRxiv. 2026 Nov 02. pii: 2026.11.01.763250. [Epub ahead of print]
      Chromatin architecture regulates gene expression, and it is maintained by architectural proteins such as CTCF and the cohesin complex. In Epstein-Barr virus infected cells, viral chromatin organization is stabilized through the interaction between PARP1 and CTCF, ensuring maintenance of latent gene expression. EBV⁺ B cells exhibit elevated PARP1 activity, which imposes a substantial metabolic burden due to NAD⁺ consumption by PARP1 itself. We demonstrate that efficient EBV infection and B-cell transformation rely on the NAD salvage pathway to sustain PARP1 activity and CTCF-cohesin chromatin folding. Pharmacologic inhibition of the rate-limiting enzyme NAMPT with FK866 phenocopies the chromatin architectural disruption induced by PARP1 and changes in NAD levels affects CTCF/cohesin chromatin architectural remodeling and loop extrusion. Moreover, NAMPT inhibition reduces tumor burden in EBV⁺ xenograft models. These findings identify a critical metabolic dependency linking NAD⁺ homeostasis to CTCF/cohesin mediated chromatin architecture and reveal a therapeutic vulnerability in EBV-associated malignancies.
    DOI:  https://doi.org/10.64898/2026.11.01.763250
  37. Mol Cell. 2026 Nov 16. pii: S1097-2765(26)00747-1. [Epub ahead of print]
      Heterochromatin protein 1α (HP1α) is a core component of heterochromatin, forming subnuclear condensates whose regulation and function remain poorly understood. Although RNA has been implicated in heterochromatin organization, how RNA influences HP1α localization remains unclear. Here, we develop an image-based CRISPR screening platform to systematically identify regulators of HP1α condensates and identify RNA processing as a central pathway. Perturbations that disrupt RNA processing increase HP1α-RNA interactions and reduce its association with chromatin, leading to loss of silencing. These findings establish RNA processing as a post-transcriptional mechanism that regulates HP1α localization and heterochromatin by altering the composition and nuclear distribution of HP1α-associated RNAs. More broadly, our work reveals functional crosstalk between RNA processing and chromatin organization, providing a framework for how RNA metabolism can influence nuclear architecture and gene regulation.
    Keywords:  HP1α; RNA; RNA processing; biomolecular condensates; chromatin; heterochromatin; intron retention
    DOI:  https://doi.org/10.1016/j.molcel.2026.10.027
  38. Res Sq. 2026 Nov 05. pii: rs.3.rs-11393609. [Epub ahead of print]
      IL-4 is a pleiotropic cytokine that was first identified as a B cell co-mitogen over 30 years ago1. However, how IL-4 signaling mechanistically supports B cell proliferation is incompletely understood. Here, we find that the cholesterol biosynthetic program is transcriptionally upregulated by IL-4 signaling during the early B cell response to influenza virus infection and is required for B cell activation in vivo. Induction of lipid synthesis genes required both STAT6 and SREBP2 transcription factors, allowing IL-4 activated B cells to enter the cell cycle and proliferate in the absence of lipids. Genetic inhibition of de novo cholesterol synthesis via SREBP2 deletion reduced plasmablasts and subsequent germinal center B cell formation at steady state and following influenza infection. SREBP2-deficency blocked IL-4 mediated cell cycle entry, ER expansion, and subsequent proliferation in a cholesterol dependent manner. Further mechanistic studies revealed that ER cholesterol content promoted sustained STAT6 signaling associated with ER expansion and B cell survival. In sum, we demonstrate that the well-known ability of IL-4 to act as a B cell growth factor is through a previously unknown rewiring of specific lipid anabolic programs, relieving sensitivity of cells of environmental nutrient availability.
    DOI:  https://doi.org/10.21203/rs.3.rs-11393609/v1
  39. J Lipid Res. 2026 Nov 17. pii: S0022-2275(26)00232-4. [Epub ahead of print] 101202
      Elevated circulating very-long-chain ceramides are associated with increased cardiovascular disease risk, yet the underlying mechanisms remain unclear. Here, we identify ceramide synthase 2 (CerS2)-derived Cer 24:0 as a critical mediator of endothelial senescence-a key driver of cardiovascular disease progression. CerS2 was upregulated in senescent HUVECs and in aortas from aged mice, coinciding with marked Cer 24:0 elevation. Isotopic labeling confirmed that excess Cer 24:0 accumulates in mitochondria, triggering structural damage and mtDNA release into the cytosol, thereby activating the cGAS-STING pathway, driving a pro-inflammatory cascade and sub-lethal stress that are tightly linked to cellular senescence. Accordingly, reducing Cer 24:0 content in senescent HUVECs by CerS2 knockdown restored mitochondrial function and reversed senescence phenotypes. Our findings demonstrate that CerS2-driven Cer 24:0 accumulation within mitochondria of senescent endothelial cells disrupts mitochondrial integrity and endothelial homeostasis, identifying CerS2 as a potential target to mitigate endothelial senescence.
    Keywords:  Cer 24:0; Ceramide synthase 2; cGAS-STING; cellular senescence; mitochondrial damage
    DOI:  https://doi.org/10.1016/j.jlr.2026.101202
  40. bioRxiv. 2026 Nov 13. pii: 2026.11.11.765941. [Epub ahead of print]
      Neuropathic pain is common and debilitating among diabetics. The reactive glycolytic metabolite methylglyoxal (MGO) is strongly associated with painful diabetic neuropathy. MGO triggers pain through activation of the integrated stress response (ISR). The underlying molecular mechanisms are unclear. Here, we show that general control nonderepressible 2 (GCN2) kinase acts as a conserved sensor that bridges glycolytic and mitochondrial dysfunction to pain hypersensitivity. In human sensory neurons derived from dorsal root ganglion (DRG), MGO increased eIF2α phosphorylation and suppressed global translation. These effects were blocked upon inhibition of GCN2. Unbiased ribosome profiling of mouse DRG revealed that MGO triggered repression of mRNAs that encode components of the electron transport chain. Based on this observation, mitochondrial dysfunction was examined as a potential upstream trigger for GCN2 activation. MGO directly glycated mitochondrial complex I and increased the NADH/NAD + ratio. Correcting this redox imbalance via expression of a mitochondrial-targeted bacterial NADH oxidase (mitoLbNOX) prevented ISR activation by MGO. In a streptozotocin-induced mouse model of diabetic neuropathy, pharmacological GCN2 inhibition or sensory neuron-specific conditional deletion significantly attenuated mechanical allodynia. Calcium imaging revealed that genetic deletion of GCN2 reduced calcium influx in response to an agonist of TRPA1. Finally, expression of mitoLbNOX using adeno-associated viruses (AAV) in DRG sensory neurons in vivo reduced streptozotocin-induced mechanical hypersensitivity. Our findings demonstrate that GCN2 is a central, conserved driver of translational dysregulation downstream of mitochondrial redox stress in diabetic pain. This work highlights the critical role of mitochondrial function and translational control as key drivers of painful diabetic neuropathy.
    DOI:  https://doi.org/10.64898/2026.11.11.765941